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Abstract 
     The present study included 40 female subjects. They were classified into two groups: group I included 20 females 
diagnosed as primary hypothyroidism with age ranged between 45 – 65 years and group II included 20 ages matched 
normal female volunteers and served as control group. Insulin like growth factor -1, (IGF-1) cholesterol, triglycerides, 
Thyroid stimulating hormone, thyroxine-3 (T3) and thyroxine-4 (T4) hormones were measured in both groups. The 
obtained results revealed that, there was a significant decrease in IGF-1 level in group I, when compared to control group 
(P ≤ 0.01). Correlation studies showed that IGF-1 is strongly positively correlated with T3 (R=0.81, P ≤ 0.01) and 
moderately positively correlated with T4 (R= 0.58, P ≤ 0.05). Meanwhile, it was moderately negatively correlated with 
cholesterol (R= 0.6, P ≤ 0.05). The results indicate that IGF-1 deficiency in elder women suffering from  ٍ◌hypothyroidism 
may have a direct relation in the pathogenesis of hypercholesterolemia. 
Keywords: Hypercholesterolemia: Insulin like growth factor -1: Elderly: Hypothyroidism: growth hormone: 
thyroid hormone: cholesterol.  
 
1. Introduction 
    Insulin like growth factor-1 is the precise test for human growth human activity (HGH). It is a polypeptide 
hormone synthesized in the liver after stimulation of the pituitary gland. It is also called Somatomedine C. 
Clinical studies have shown that pituitary human growth hormone administration to the elderly has significantly 
increased IGF-1, which improves cognizance, muscle and bone strength, libido enhancement, and athletic 
performance. 
    Low levels of IGF-1 are described in hypopituitarism, diabetes mellitus, dwarfism, malnutrition, 
hypothyroidism, maternal deprivation syndrome, pubertal delay, cirrhosis, hepatoma and some cases of short 
stature and normal growth hormone response. High levels of IGF-1 are described in adolescence, true precocious 
puberty, pregnancy, obesity, pituitary gigantism, acromegaly and diabetic retinopathy (Werstemark et al., 2006).  
    Hypothyroidism cases pronounced hypercholesterolemia. This may be due to an increase in both low density 
lipoprotein cholesterol (LDL-C) and high density lipoprotein cholesterol (HDL-C) (Gross et al., 2008). The 
mechanisms responsible for these hypothyroidism related changes are completely understood. During 
hypothyroidism and spite of the hypercholesterolemia; cholesterol synthesis estimated by hydroxyl methyl 
glutaryl-CoA reductase activity in the liver is often decreased (Field et al., 2008). However, degradation of 
lipoproteins is decreased secondary to a reduction in the number of LDL receptors (Chait et al., 2009). It has 
been suggested that the decrease in lipoprotein lipase activity and/or salt resistant liver lipase activity are major 
contributors to the abnormalities in lipid profile in hypothyroidism (Valdemarsson, 2006). On the other hand, 
several data pointed to a relationship between hypothyroidism, growth hormone activity and 
hypercholesterolemia. It has been suggested that, in thyroidectomized rats, the main cause of 
hypercholesterolemia might be the effect of hypothyroidism on the secretion of growth hormone. The 
administration of growth hormone to these thyroidectomized rats was essentially as effective in preventing the 
occurrence of hypercholesterolemia as the thyroid extract (Bayers et al., 1970). It is not known in what way 
these effects are mediated through growth hormone, whether directly or by its chief mediator insulin like growth 
factor-1 (Somatomedine C).  
The aim of this work is to study the relation between somatomedine C and pathogenesis of 
hypercholesterolemia in elder women suffering from hypothyroidism. 
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2. Subjects and methods 
2.1. Subjects 
    The study included 40 female subjects. They were classified into two groups: group I included 20 females 
suffering from primary hypothyroidism, aged between 45- 65 years and group II of 20 females, age matched 
normal female volunteers. 
    Through history and clinical examination with special emphasis on excluding history of drug intake that might 
alter serum lipids such as diuretics and beta-blockers. None of the patients had clinical or biochemical evidences 
of diabetes, liver or kidney diseases nor had any of the primary hyperlipoproteinaemia. Nutritional history was 
obtained and a good nutritional status was ensured. 
2.2. Chemical investigation  
    Cholesterol and triglycerides “mg / dl” were determined according to the methods of Fossati and Prencipe 
(1982). 
    Insulin like growth factor-1 (Somatomedine C), TSH, T3 and T4 were carried out by radio-immunoassay 
technique using DPD kits “Diagnostic Products, Los Angeles, USA” (Westgard and klee, 1987). 
2.3. Statistical analysis: 
  The results were computed and statistical analysis was done. Student’s T-test and correlation study between 
various parameters were done. 
3. Results and discussion 
   The results of this study revealed a low IGF-1 in hypothyroid patients when compared with the normal subjects 
(table 1). In hypothyroid patients both reduced and unchanged IGF-1 levels have been reported (Westermark et 
al., 2006). Several reports have documented growth hormone dysfunction in hypothyroid patients. However, the 
degree of growth hormone secretory dysfunction in humans with hypothyroidism has not been established. 
Indeed, approximately 50 % of patients with hypothyroidism have putatively normal growth hormone secretion 
in response to pharmacologic stimuli (Chernausek and Turner, 1989). In the present study, we measured IGF-1 as 
it was concluded that IGF-1 is a good reflection of growth hormone secretion; so the reduced IGF-1 levels 
observed is a reflection of decreased growth hormone secretion in hypothyroidism. The reasons for growth 
hormone decreased secretion may be due to several causes, among them, altered synthesis and release of GH-RH 
(Katakami et al., 1988), changes of sensitivity of the pituitary gland to GH-RH (Chernausek and Turner, 1989), 
and reduced growth hormone synthesis due to reduced transcription of the growth hormone gene (Marital et al., 
1977). On the other hand reduced IGF-1 observed in the prsent study may not be solely due to decreased growth 
hormone release. It is a well known fact that serum IGF-1 level responds to both protein and energy (Isley et al., 
1983), and suboptimal nutrition is perhaps the most common cause of low IGF-1 level (Bellet al., 1984), 
Hypothyroidism is usually accompanied by loss of appetite and impaired gastrointestinal tract motility which 
result in a state of malnutrition (Larson and Ingbar, 1992). However, some authors reported that IGF-1 
concentration was higher in thyrotoxic patients despite nutritional deficiency and decreased when they become 
euthroid, supporting the role of thyroid hormone in IGF-1 production (Westermark et al., 2006). Moreover, 
exogenous growth hormone failed to raise IGF-1 levels in hypothyroid rate denoting a direct role for thyroid 
hormone in the production of IGF-1 (Colonna et al., 1991). Also, in keeping with this view, is the finding that T3, 
in addition to growth hormone and cortisol, are needed to restore plasma IGF-1 to normal level in 
hypothyrectomized rats (Schalch et al., 2007). Now we can say that the low IGF-1 level observed in the present 
study is due to decreased growth hormone secretion and due to decreased thyroid hormones stimulatory effect on 
IGF-1 production. 
    Correlation studies (Figure 1-3) showed that IGF-1 is strongly positively correlated with T3 (R=0.81, P<0.01), 
and moderately positively correlated with T4 (R=0.85, P<0.05). Meanwhile, it is moderately negatively 
correlated to cholesterol (R=0.6, P< 0.05). In agreement with our results a positive linear correlation was found 
between IGF-1 and T4 and a negative correlation between IGF-1 and plasma cholesterol (Hoogerbrugge et al., 
1989). Moreover, physiological doses of growth hormone could reduce hypercholesterolemia in hypothyroid rats 
(Hoogerbrugge et al., 1989). On the other hand, it was suggested that hypercholesterolemia observed in 
hypothyroidism is due to lack of a stimulatory effect of thyroid hormones on lipoprotein lipases claiming direct 
effect for thyroid hormones in hypercholesterolemia (Valdemarsson, 2006). The fact that we found a positive 
correlation between IGF-1 and T3, T4 and a negative correlation between IGF-1 and cholesterol suggest a direct 
role of IGF-1 in the process of hypercholesterolemia. 
    The question is how IGF-1 deficiency can induce hypercholesterolemia. It has recently been showed that IGF-
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1 augments the binding capacity and uptake of LDL (Veldhuis et al., 1987). Meanwhile, it was also 
demonesterated that a defect of receptor mediated LDL catabolism in hypothyroidism is present (Thompson et 
al., 1981). It was also reported that studies of the different lipoprotein classes revealed an increase predominantly 
of LDL cholesterol and only a minor changes in the concentrations of high density lipoprotein (HDL) cholesterol 
(Abrams and Grundy, 1981), i.e. the main cholesterol fraction that is increased in hypothyroidism is the LDL 
cholesterol.  
    From the above data, we may conclude that hypercholesterolemia present in hypothyroidism is mainly due to 
the increased LDL cholesterol which is due to lack of IGF-1 stimulatory effect on LDL-receptor mediated uptake. 
The proof that IGF-1 deficiency has a role in the pathogenesis of hypercholesterolemia in primary 
hypothyroidism may raise a question about its role in mediated several clinical aspects of hypothyroidism. For 
example, IGF-1 has a stimulatory effect on myelination by stimulating the activity of the myelin marker enzyme 
2, 3 cyclic nucleotide 3-phosphohydrolase (McMorris et al., 1986) that may suggest a role for IGF-1 deficiency 
in neurological manifestations of hypothyroidism. Indeed primary hypothyroidism may clinically reflect a 
multiple hormonal deficiency disorder including T3, T4, growth hormone and IGF-1 deficiencies. 
4. Conclusion  
     IGF-1 is decreased in primary hypothyroidism which may be due to decreased hormone secretion and/or lack 
of direct thyroid hormone stimulation on IGF-1 production. IGf-1 deficiency has a role in the pathogenesis of 
hypercholesterolemia through lack of this stimulatory effect on LDL uptake and degradation. 
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Table (1): Serum T3, T4, TSH, Cholesterol, triglycerides and IGF-1 levels of tested subjects (Means ± S. E., n = 
20) 
Groups 
T3 
(ng/dl) 
T4 
(ug/dl) 
TSH (uU/ml) Cholesterol 
(mg/dl) 
Triglycerides 
(mg/dl) 
IGF-1 
(ng/dl) 
(I) 0.27±0.16 0.62±0.80 33.20±17.43* 274.4±95.4* 152.5±37.43 4.29±2.52 
(II) 1.80±0.23** 7.40±0.81** 5.600±0.380 193.2±26.3 130.3±14.85 12.95±3.57** 
*Significant at < 0.05 
**Highly Significant at < 0.01 
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